Home/Filings/4/0000891839-20-000118
4//SEC Filing

Yanni Barbara 4

Accession 0000891839-20-000118

CIK 0001205922other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:19 PM ET

Size

8.2 KB

Accession

0000891839-20-000118

Insider Transaction Report

Form 4
Period: 2020-05-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-05-14+15,67915,679 total
    Exercise: $3.95From: 2021-05-14Common Stock (15,679 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $7.78From: 2020-05-15Common Stock (7,718 underlying)
    7,718
  • Stock Option (Right to Buy)

    Exercise: $13.60Exp: 2027-09-15Common Stock (6,396 underlying)
    6,396
Footnotes (3)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  • [F3]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.

Issuer

VACCINEX, INC.

CIK 0001205922

Entity typeother

Related Parties

1
  • filerCIK 0001610561

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:19 PM ET
Size
8.2 KB